P-437. Prevalence of Hepatitis B Co-infection in People with HIV by Birth Cohort– Potential Impact of HBV Vaccination Availability
Claire Lee(University of Toronto), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Tarfa Verinumbe(Albert Einstein College of Medicine), Mark Sulkowski(Johns Hopkins University), LaQuita N. Snow(National Institutes of Health), Jeanne Keruly(Johns Hopkins University), Richard D. Moore(Johns Hopkins University), Joyce Jones(Johns Hopkins University), Anthony T. Fojo(Johns Hopkins University)
Cited by 0
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
|Gastroenterology|2015|799
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728